Former Sen. Ben Sasse shines the spotlight on a possible breakthrough for pancreatic cancer by CNBC Markets | April 11, 2026 1:11 am | US Markets Former Sen. Ben Sasse is taking Revolution Medicines’ daraxonrasib, which has shown promise as a treatment for pancreatic cancer.
